National Trends in Parental Human Papillomavirus Vaccination Intentions and Reasons for Hesitancy, 2010–2015

Hanson, Kayla E.; Koch, Brandon; Bonner, Kimberly; McRee, Annie-Laurie; Basta, Nicole E.

doi:10.1093/cid/ciy232

Cited by 31 publications

(23 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite the comprehensive monitoring and research that have contributed to characterizing the favorable safety profile of HPV vaccines, concerns about AEs continue to be expressed by some members of the public, and even by some health care providers, and could be contributing to suboptimal HPV vaccination coverage. 42,43 Furthermore, nonspecific safety concerns have evolved over time since 4vHPV was first licensed in 2006 and could continue to evolve. 44 Apprehensions about POI, POTS, CRPS, and putative autoimmune or autoinflammatory syndrome induced by adjuvants (ASIA) and their potential associations with HPV vaccination emerged after substantial reassuring postlicensure safety data for 4vHPV were already available.…”

Section: Discussionmentioning

confidence: 99%

Safety of the 9-Valent Human Papillomavirus Vaccine

Shimabukuro

Marquez

et al. 2019

Pediatrics

View full text Add to dashboard Cite

BACKGROUND: The 9-valent human papillomavirus vaccine (9vHPV) was approved for females and males aged 9 to 26 years in 2014. We analyzed postlicensure surveillance reports to the Vaccine Adverse Event Reporting System (VAERS). METHODS: We searched VAERS data for US reports of adverse events (AEs) after 9vHPV from December 2014 through December 2017. We calculated reporting rates and conducted empirical Bayesian data mining to identify disproportional reporting. Physicians reviewed reports for selected prespecified conditions.

show abstract

Section: Discussionmentioning

confidence: 99%

Safety of the 9-Valent Human Papillomavirus Vaccine

Shimabukuro

Marquez

et al. 2019

Pediatrics

View full text Add to dashboard Cite

show abstract

“…Parental hesitancy towards HPV vaccine uptake has been attributed to lack of information regarding the 2-and 3-dose series, side effects, and safety of the HPV vaccine. 20,22,37,[48][49][50] In addition, recommendations for HPV vaccination may be attributed to area-based factors (eg, racial / ethnic composition, areabased socioeconomic status), social context (eg, social norms of behavior, knowledge, and risk perception), physical circumstances (eg, geographic accessibility), and economic conditions (eg, time demands, work / /school schedule, costs) in RGV. 51 Besides healthcare provider recommendations, the main reasons reported for not getting their child vaccinated are age (too young), child was not sexually active, safety concerns, and other reasons.…”

Section: Reasons For Low Vaccination Ratesmentioning

confidence: 99%

Parental knowledge gaps and barriers for children receiving human papillomavirus vaccine in the Rio Grande Valley of Texas

Victory

Kuo

et al. 2019

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Purpose: Despite its availability for more than a decade, the human papillomavirus (HPV) vaccine has low uptake in Texas (49%). The objective of this study was to understand parental knowledge and attitudes about HPV and the HPV vaccine as well as child experience with the HPV vaccine among a medically underserved, economically disadvantaged population. Methods: As part of a Cancer Prevention Research Institute of Texas-funded project to improve HPV vaccination rates, we surveyed parents / guardians of 4 th-12 th graders (ages 9-17) in the Rio Grande City Consolidated Independent School District (RGCCISD). Descriptive statistics were used to describe parents' knowledge and attitude and children's vaccine experience. Results: Of the 7,055 surveys distributed, 622 (8.8%) were returned. About 84% of the respondents were female. About 57.1% of the parents /guardians had female RGCCISD students with a mean age of 11.7 ± 1.8 years. Overall, 43.9% reported receiving a healthcare provider recommendation and 32.5% had their child vaccinated. Higher percentages were reported if the respondent was female and had a female child aged ≥15 years old. Among survey respondents, 28.2% reported their child initiated the HPV vaccine and 18.8% completed the series. Barriers of uptake included work / school schedule conflicts and no healthcare provider recommendation. Conclusions: There are still prominent gaps in parents' and students' complete understanding of HPV vaccination, gender preferences for vaccination, and provider recommendations. Future interventions must target men and minority populations in order to increase knowledge and awareness about HPV, the HPV vaccine, and HPV-associated cancers.

show abstract

“…However, although previous investigations involving the knowledge, attitudes, and behaviors about HPV vaccine in different countries and populations have been carried out recently, [8][9][10][11][12] to this end there are limited reports with regard to the prevalence of HPV vaccine hesitancy for a child among parents. [13][14][15] This survey, therefore, was initiated with the intention of generating new insights that may lead to interventions to improve HPV vaccination rates of adolescents aged 12 and 13 years in Italy. This cross-sectional survey was designed to establish the current status of vaccine hesitancy related to HPV and to identify the determinants of the hesitancy among parents of adolescents aged 12 and 13 years in Italy.…”

Section: Introductionmentioning

confidence: 99%

HPV vaccine hesitancy among parents in Italy: a cross-sectional study

Polla

Pelullo

Napolitano

et al. 2020

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

This cross-sectional survey determined the vaccine hesitancy related to Human papillomavirus (HPV) and the determinants among parents of adolescents aged 12 and 13 years in Italy. Data was collected through a self-administered questionnaire. Two-thirds of the parents (66.7%) had heard of HPV infection and knew that the vaccination was a preventive measure. Parents who had vaccinated their child against the HPV were more likely to have this knowledge. The vast majority (88%) considered the immunization useful for the prevention of HPV-related cancers with an average value of 8.4. This positive attitude was higher among parents who had heard of HPV infection and knew that vaccination was a preventive measure, who had received information from physicians, who had vaccinated their child against the HPV, who were concerned that their child could contract the HPV infection, and who needed information on HPV vaccination. More than half (57.9%) self-reported that they had vaccinated their child against HPV and only 6.2% had delayed the administration of a dose. One-third (33.3%) were hesitant toward anti-HPV vaccination with a total Parent Attitudes about Childhood Vaccines Survey (PACV) score ≥50. Unmarried respondents, those who had not heard of HPV infection and did not know that the vaccination was a preventive measure, who did not believe that the vaccination was useful for the prevention of HPV-related cancers, and who needed information on HPV vaccination were more likely to be hesitant. Communication and education strategies must be undertaken to ensure that parents are fully informed and health-care professionals should provide materials with details regarding the risk of acquiring a HPV infection and vaccine usefulness.

show abstract

National Trends in Parental Human Papillomavirus Vaccination Intentions and Reasons for Hesitancy, 2010–2015

Cited by 31 publications

References 26 publications

Safety of the 9-Valent Human Papillomavirus Vaccine

Safety of the 9-Valent Human Papillomavirus Vaccine

Parental knowledge gaps and barriers for children receiving human papillomavirus vaccine in the Rio Grande Valley of Texas

HPV vaccine hesitancy among parents in Italy: a cross-sectional study

Contact Info

Product

Resources

About